Tau is essential to β-amyloid-induced neurotoxicity
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Senile plaques and neurofibrillary tangles, the two hallmark lesions of Alzheimer's disease, are the results of the pathological deposition of proteins normally present throughout the brain. Senile plaques are extracellular deposits of fibrillar β-amyloid peptide (Aβ); neurofibrillary tangles represent intracellular bundles of self-assembled hyperphosphorylated tau proteins. Although these two lesions are often present in the same brain areas, a mechanistic link between them has yet to be established. In the present study, we analyzed whether tau plays a key role in fibrillar Aβ-induced neurite degeneration in central neurons. Cultured hippocampal neurons obtained from wild-type, tau knockout, and human tau transgenic mice were treated with fibrillar Aβ. Morphological analysis indicated that neurons expressing either mouse or human tau proteins degenerated in the presence of Aβ. On the other hand, tau-depleted neurons showed no signs of degeneration in the presence of Aβ. These results provide direct evidence supporting a key role for tau in the mechanisms leading to Aβ-induced neurodegeneration in the central nervous system. In addition, the analysis of the composition of the cytoskeleton of tau-depleted neurons suggested that the formation of more dynamic microtubules might confer resistance to Aβ-mediated neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations support the idea that Aβ and Tau act together and that Aβ is upstream of Tau [114,115], positioning Aβ as the initiator and Tau as the executor in the pathogenetic process [116].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [115]
In the citing paper
“Indeed, Tau has been implicated in the synaptotoxicity induced by Aβ exposure [102].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [102]
In the citing paper
“Thus, cultured neurons from tau knockout (Tau−/−) mice are not susceptible to Aβ-induced synaptic damage and neurotoxicity (Rapoport et al., 2002; Nussbaum et al., 2012; Zempel et al., 2013) or to Aβ-induced defects in axonal transport (Vossel et al., 2011).”
From Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice (2017) · cites this paper as Rapoport et al., 2002
In the citing paper
“Neurons without tau are resistant to Aβ toxicity, and APP transgenic mice lacking tau develop Aβ pathology but remain cognitively normal (Rapoport et al., 2002; Roberson et al., 2007).”
From CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease (2018) · cites this paper as Rapoport et al., 2002
In the citing paper
“Data from cell and animal models show that tau is also a mediator of Aβ-induced toxicity46–48.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [46]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Assay of proteins in the presence of interfering materials
Bensadoun, A., & Weinstein, D. (1976) · Analytical Biochemistry · doi:10.1016/s0003-2697(76)80064-4 · Cited by 3,179
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
Bottenstein, J. E., & Sato, G. H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.514 · Cited by 2,276
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,459
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Research works printed but not linked: 2
- M P Vitek, C G Rasool, F de Sauvage, S M Vitek, R T Bartus, B Beer, R A Ashton, A F Macq, J M Maloteaux, A J Blume Brain Res 464, 121–131 (1988).
- J G Wood, S S Mirra, N L Pollock, L I Binder Proc Natl Acad Sci USA 508, 320–324 (1986).
Cited by
Items 401–500 of 971
Investigating Interventions in Alzheimer's Disease with Computer Simulation Models
Proctor, C. J., Boche, D., Gray, D. A., & Nicoll, J. A. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073631 · Cited by 44
Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer’s Disease
Paudel, Y. N., Angelopoulou, E., Jones, N. C., O'Brien, T. J., Kwan, P., Piperi, C., Othman, I., & Shaikh, M. F. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00460 · Cited by 44
Peters, F., Salihoglu, H., Pratsch, K., Herzog, E., Pigoni, M., Sgobio, C., Lichtenthaler, S. F., Neumann, U., & Herms, J. (2019) · The EMBO Journal · doi:10.15252/embj.2019102345 · Cited by 44
Golovyashkina, N., Penazzi, L., Ballatore, C., Smith, A. B., Bakota, L., & Brandt, R. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0049-0 · Cited by 44
Temperature and toxic Tau in Alzheimer's disease: new insights
Carrettiero, D. C., Santiago, F. E., Motzko-Soares, A. C. P., & Almeida, M. C. (2015) · Temperature · doi:10.1080/23328940.2015.1096438 · Cited by 44
Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice
Tan, D. C. S., Yao, S., Ittner, A., Bertz, J., Ke, Y. D., Ittner, L. M., & Delerue, F. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171058 · Cited by 43
Feinstein, H. E., Benbow, S. J., LaPointe, N. E., Patel, N., Ramachandran, S., Do, T. D., Gaylord, M. R., Huskey, N. E., Dressler, N., Korff, M., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13604 · Cited by 43
Amadoro, G., Latina, V., Corsetti, V., & Calissano, P. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165584 · Cited by 43
Qureshi, H. Y., Han, D., MacDonald, R., & Paudel, H. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084615 · Cited by 43
Corsetti, V., Borreca, A., Latina, V., Giacovazzo, G., Pignataro, A., Krashia, P., Natale, F., Cocco, S., Rinaudo, M., Malerba, F., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa039 · Cited by 42
Tau Aggregates and Tau Pathology
Hernández, F., & Avila, J. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14414 · Cited by 42
Is tau ready for admission to the prion club?
Hall, G. F., & Patuto, B. A. (2012) · Prion · doi:10.4161/pri.19912 · Cited by 42
Heinisch, J. J., & Brandt, R. (2016) · Microbial Cell · doi:10.15698/mic2016.04.489 · Cited by 42
Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons
Khan, S. S., LaCroix, M., Boyle, G., Sherman, M. A., Brown, J. L., Amar, F., Aldaco, J., Lee, M. K., Bloom, G. S., & Lesné, S. E. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1886-z · Cited by 41
Invertebrate Models of Alzheimer's Disease
Mhatre, S. D., Paddock, B. E., Saunders, A. J., & Marenda, D. R. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121204 · Cited by 41
Guo, P., Zeng, M., Wang, S., Cao, B., Liu, M., Zhang, Y., Jia, J., Zhang, Q., Zhang, B., Wang, R., et al. (2022) · Molecules · doi:10.3390/molecules27082488 · Cited by 41
The Effects of Soluble A.β Oligomers on Neurodegeneration in Alzheimer's Disease
Brouillette, J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990498 · Cited by 41
Pharmacological Modulators of Tau Aggregation and Spreading
Dominguez‐Meijide, A., Vasili, E., & Outeiro, T. F. (2020) · Brain Sciences · doi:10.3390/brainsci10110858 · Cited by 41
“Untangling” Alzheimer's Disease and Epilepsy
Scharfman, H. E. (2012) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-12.5.178 · Cited by 41
Chen, Z., Chen, B., Xu, W., Liu, R., Yang, J., & Yu, C. (2012) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2012.08.003 · Cited by 40
Limited hippocampal neurogenesis in SAMP8 mouse model of Alzheimer's disease
Gang, B., Yue, C., Han, N., Xue, H., Li, B., Sun, L., Li, X., & Zhao, Q. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.039 · Cited by 40
Lung endothelium, tau, and amyloids in health and disease
Balczon, R., Lin, M. T., Voth, S. B., Nelson, A. R., Schupp, J. C., Wagener, B. M., Pittet, J., & Stevens, T. (2023) · Physiological Reviews · doi:10.1152/physrev.00006.2023 · Cited by 40
Leugers, C. J., Koh, J. Y., Hong, W., & Lee, G. S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00161 · Cited by 40
Evidence of a Cardiovascular Function for Microtubule-Associated Protein Tau
Betrie, A. H., Ayton, S., Bush, A. I., Angus, J. A., Lei, P., & Wright, C. E. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161093 · Cited by 40
Qin, X., Wang, Y., & Paudel, H. K. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.04.018 · Cited by 40
Future directions in the treatment of Alzheimer?s disease
Bullock, R. A. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.4.303 · Cited by 40
Long-term depression links amyloid-β to the pathological hyperphosphorylation of tau
Taylor, H. B. C., Emptage, N. J., & Jeans, A. F. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109638 · Cited by 39
Chen, G., Initiative, A. D. N., Shu, H., Chen, G., Ward, B. D., Antuono, P. G., Zhang, Z., & Li, S.-J. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160537 · Cited by 39
Does the term ‘trophic’ actually mean anti-amyloidogenic? The case of NGF
Calissano, P., Amadoro, G., Matrone, C., Ciafrè, S., Marolda, R., Corsetti, V., Ciotti, M. T., Mercanti, D., Luzio, A. D., Severini, C., et al. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.38 · Cited by 39
Why therapies for Alzheimer’s disease do not work: Do we have consensus over the path to follow?
Amtul, Z. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.09.003 · Cited by 39
Amyloid beta1-42 peptide regulates microtubule stability independently of tau
Pianu, B., Lefort, R., Thuiliere, L., Tabourier, E., & Bartolini, F. (2014) · Journal of Cell Science · doi:10.1242/jcs.143750 · Cited by 39
Muñoz-Cabrera, J. M., Sandoval-Hernández, A. G., Niño, A., Báez, T., Bustos-Rangel, A., Cardona‐Gómez, G. P., Múnera, A., & Arboleda, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223578 · Cited by 39
Xu, A., Zeng, Q., Tang, Y., Wang, X., Yuan, X., Zhou, Y., & Li, Z. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.585476 · Cited by 39
Modi, K. K., Jana, A., Ghosh, S., Watson, R. L., & Pahan, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180602 · Cited by 39
Advances on the Understanding of the Origins of Synaptic Pathology in AD
Lacor, P. (2007) · Current Genomics · doi:10.2174/138920207783769530 · Cited by 38
Adeno‐associated virus‐based Alzheimer's disease mouse models and potential new therapeutic avenues
Ittner, L. M., Klugmann, M., & Ke, Y. D. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14637 · Cited by 38
Ávila, J., Pallas‐Bazarra, N., Bolós, M., Sayas, C. L., & Hernández, F. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1131269 · Cited by 38
Animal Models for Alzheimer’s Disease and Frontotemporal Dementia: A Perspective
Götz, J., & Götz, N. N. (2009) · ASN Neuro · doi:10.1042/an20090042 · Cited by 38
Axonal Transport and Mitochondrial Dysfunction in Alzheimer's Disease
Riemer, J., & Kins, S. (2013) · Neurodegenerative Diseases · doi:10.1159/000342020 · Cited by 38
In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease
Mak, E., Bethlehem, R. A. I., Romero-García, R., Červenka, S., Rittman, T., Gabel, S., Surendranathan, A., Bevan-Jones, W. R., Passamonti, L., Rodríguez, P. V., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.08.005 · Cited by 38
Dahran, N. A., Abd‐Elhakim, Y. M., Mohamed, A. A.-R., Abd-Elsalam, M. M., Said, E. N., Metwally, M. M. M., Abdelhamid, A. E.-S., Hassan, B. A., Alsieni, M., Alosaimi, M. E., et al. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113537 · Cited by 38
Anderson, K. L., & Ferreira, A. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20018 · Cited by 37
Self-citationAlzheimer's Disease and Prion Protein
Zhou, J. (2013) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2013.v2.2.35 · Cited by 37
Wang, X., Williams, D., Müller, I., Lemieux, M., Dukart, R., Maia, I. B. L., Wang, H., Woerman, A. L., & Schmitt-Ulms, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-52543-5 · Cited by 37
Virulent Pseudomonas aeruginosa infection converts antimicrobial amyloids into cytotoxic prions
Voth, S. B., Gwin, M. S., Francis, C. M., Balczon, R., Frank, D. W., Pittet, J., Wagener, B. M., Moser, S. A., ALEXEYEV, M. F., Housley, N. A., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000051rrr · Cited by 37
Biological basis for amyloidogenesis in Alzheimer’S disease
Andreeva, T. V., Lukiw, W. J., & Rogaev, E. I. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917020043 · Cited by 36
Yang, J., Shen, N., Shen, J., Yang, Y., & Li, H.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03867-x · Cited by 36
Neuronal degeneration, synaptic defects, and behavioral abnormalities in tau45-230 transgenic mice
Lang, A. E., Riherd Methner, D. N., & Ferreira, A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.017 · Cited by 35
“It is worth noting that most of wild type neurons did not show any sign of degeneration at this stage (Figure 7A & B, see also Rapoport et al., 2002).”
BackgroundResultSelf-citationRole of Cofilin in Alzheimer’s Disease
Wang, Q., Yuan, W., Yang, X., Wang, Y., Li, Y., & Qiao, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.584898 · Cited by 35
Zhuang, X., Jie, L., Song, Y., Ban, R., Zhao, X., Xia, Z., Wang, Z., & Zhang, G. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08815-z · Cited by 35
A Tangled Web – Tau and Sporadic Parkinson's Disease
Wray, S., & Lewis, P. A. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00150 · Cited by 35
Sources of Extracellular Tau and its Signaling
Avila, J., Simón, D., Díaz-Hernández, M., Pintor, J., & Hernández, F. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131832 · Cited by 35
Takamura, A., Sato, Y., Watabe, D., Okamoto, Y., Nakata, T., Kawarabayashi, T., Oddo, S., LaFerla, F. M., Shoji, M., & Matsubara, E. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.04.038 · Cited by 35
CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques
Kok, E. H., Luoto, T., Haikonen, S., Goebeler, S., Haapasalo, H., & Karhunen, P. J. (2011) · Alzheimer's Research & Therapy · doi:10.1186/alzrt71 · Cited by 35
Alzheimer?s disease?a sum greater than its parts?
Adlard, P. A., & Cummings, B. J. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.016 · Cited by 35
Ostrovskaya, R. U., Vakhitova, Y. V., Kuzmina, U. S., Салимгареева, М. Х., Зайнуллина, Л. Ф., Гудашева, Т. А., Вахитов, В. А., & Середенин, С. Б. (2014) · Journal of Biomedical Science · doi:10.1186/s12929-014-0074-2 · Cited by 35
Schuh, A. F. S., Rieder, C. R. D. M., Rizzi, L., Chaves, M. L. F., & Roriz‐Cruz, M. (2011) · ISRN Neurology · doi:10.5402/2011/306905 · Cited by 35
Metal attenuating therapies in neurodegenerative disease
Mot, A. I., Wedd, A. G., Sinclair, L., Brown, D. R., Collins, S. J., & Brazier, M. W. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.170 · Cited by 34
Miyamoto, T., Kim, D., Knox, J. A., Johnson, E., & Mucke, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.666529 · Cited by 33
Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy
You, Y., Perkins, A., Cisternas, P., Muñoz, B., Taylor, X., You, Y., Garringer, H. J., Oblak, A. L., Atwood, B. K., Vidal, R., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0680-z · Cited by 33
Tau immunization: a cautionary tale?
Mably, A. J., Kanmert, D., Donald, J. M. M., Liu, W., Caldarone, B. J., Lemere, C. A., O’Nuallain, B., Kosik, K. S., & Walsh, D. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.11.022 · Cited by 33
Means, J. C., Lopez, A. A., & Koulen, P. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00781-6 · Cited by 33
Cultured cell and transgenic mouse models for tau pathology linked to β-amyloid
Bloom, G. S., Ren, K., & Glabe, C. G. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.008 · Cited by 32
A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity
Rush, T., Roth, J. R., Thompson, S. J., Aldaher, A. R., Cochran, J. N., & Roberson, E. D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104668 · Cited by 32
Gene Therapy Models of Alzheimer’s Disease and Other Dementias
Combs, B., Kneynsberg, A., & Kanaan, N. M. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3271-9_25 · Cited by 32
Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
de Leeuw, S., & Tackenberg, C. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0161-0 · Cited by 31
Tau depletion in human neurons mitigates Aβ-driven toxicity
Ng, B., Vowles, J., Bertherat, F., Abey, A. S., Kilfeather, P., Beccano-Kelly, D. A., Stefana, M. I., O'Brien, D. P., Bengoa‐Vergniory, N., Carling, P. J., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02463-2 · Cited by 31
Does Aβ 42 Have a Function Related to Blood Homeostasis?
Hardy, J. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9221-9 · Cited by 31
Tau hyperphosphorylation affects Smad 2/3 translocation
Baig, S., Helmond, Z. V., & Love, S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.045 · Cited by 31
Potentiation of Tau Aggregation by cdk5 and GSK3β
Lee, S., Hall, G. F., & Shea, T. B. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102016 · Cited by 31
Pallo, S. P., & Johnson, G. V. W. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.04.021 · Cited by 31
Seino, Y., Kawarabayashi, T., Wakasaya, Y., Watanabe, M., Takamura, A., Yamamoto‐Watanabe, Y., Kurata, T., Abe, K., Ikeda, M., Westaway, D., et al. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22516 · Cited by 31
Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases
Rodolfo, C., Ciccosanti, F., Giacomo, G. D., Piacentini, M., & Fimia, G. M. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.43 · Cited by 31
Kelliny, S., Zhou, X., & Bobrovskaya, L. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70046 · Cited by 30
Kang, H. J., Yoon, W. J., Moon, G. J., Kim, D. Y., Sohn, S., Kwon, H. J., & Gwag, B. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.004 · Cited by 30
Wang, X., Li, H., Sheng, Y., He, B., Liu, Z., Li, W., Yu, S., Wang, J., Zhang, Y., Chen, J., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116071 · Cited by 29
A short perspective on the long road to effective treatments for Alzheimer's disease
Reynolds, D. S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14581 · Cited by 29
The Cellular Distribution and Ser262 Phosphorylation of Tau Protein Are Regulated by BDNF In Vitro
Chen, Q., Zhou, Z., Zhang, L., Xu, S., Chen, C., & Yu, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091793 · Cited by 29
Harnessing BDNF Signaling to Promote Resilience in Aging
Faraji, J., & Metz, G. A. S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0961 · Cited by 29
Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells
Lines, G., Casey, J. M., Preza, E., & Wray, S. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103553 · Cited by 29
Kang, D. E., Roh, S. E., Woo, J. A., Liu, T., Bu, J. H., Jung, A., & Lim, Y. (2011) · Experimental Neurobiology · doi:10.5607/en.2011.20.2.67 · Cited by 29
Acetylation of Aβ42 at Lysine 16 Disrupts Amyloid Formation
Adhikari, R., Yang, M., Saikia, N., Dutta, C., Alharbi, W. F. A., Shan, Z. J., Pandey, R., & Tiwari, A. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00069 · Cited by 29
Smith, K. D. B., Peethumnongsin, E., Lin, H., Zheng, H., & Pautler, R. G. (2010) · Magnetic Resonance Insights · doi:10.4137/mri.s5237 · Cited by 29
Townsend, D. J., Mala, B., Hughes, E., Hussain, R., Siligardi, G., Fullwood, N. J., & Middleton, D. A. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00154 · Cited by 29
Association Between Serum Vitamins and the Risk of Alzheimer’s Disease in Chinese Population
Liu, X., Wu, P.-F., Liu, Y., Jiang, Y., Wan, M., Xiao, X., Yang, Q., Jiao, B., Liao, X., Wang, J., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215104 · Cited by 29
d-ribose and pathogenesis of Alzheimer’s disease
Javed, M., Ahmad, M. I., Javed, H., & Naseem, S. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05243-7 · Cited by 28
Watari, H., Shimada, Y., & Tohda, C. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/706487 · Cited by 28
Kim, H.-S., Sul, D., Lim, J.-Y., Lee, D., Joo, S. S., Hwang, K. W., & Park, S. (2009) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.90032 · Cited by 28
Zhao, K., Lane, G. I., Wang, L., Price, V. J., Kim, M. H., Cornwell, G. C., Fulenchek, S., Breen, G. A. M., Goux, W. J., & D’Mello, S. R. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22485 · Cited by 28
Xing, W., Gao, W., Lv, X., Xu, X., Zhang, Z., Yan, J., Mao, G., & Bu, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.637218 · Cited by 27
Targeting Tau to Treat Clinical Features of Huntington's Disease
Masnata, M., Salem, S., Jacquet, A. D. R., Anwer, M., & Cicchetti, F. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.580732 · Cited by 27
Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer’s disease
Ruthirakuhan, M. T., Herrmann, N., Suridjan, I., Abraham, E. H., Farber, I., & Lanctôt, K. L. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1258060 · Cited by 27
Shah, R. M., Anderson, K. L., Rapoport, M., & Ferreira, A. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00166-0 · Cited by 27
Self-citationTruong, A. P., Probst, G. D., Aquino, J., Fang, L. Y., Brogley, L., Sealy, J. M., Hom, R. K., Tucker, J. A., John, V., Tung, J. S., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.112 · Cited by 27
Lack of exacerbation of neurodegeneration in a double transgenic mouse model of mutant LRRK2 and tau
Mikhail, F., Calingasan, N. Y., Parolari, L., Subramanian, A., Yang, L., & Beal, M. F. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv105 · Cited by 27
PKA-CREB Signaling Suppresses Tau Transcription
Liu, H., Jin, X., Yin, X., Jin, N., Liu, F., & Qian, W. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142610 · Cited by 27
Application of Yeast to Study the Tau and Amyloid-β Abnormalities of Alzheimer's Disease
Porzoor, A., & Macreadie, I. G. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122035 · Cited by 27
Buchholz, S., Kabbani, M. A. A., Bell‐Simons, M., Kluge, L., Cagmak, C., Klimek, J., Haag, N., Iohan, L. C., Coulon, A., Costa, M. R., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.14403 · Cited by 26
Alrouji, M., Alshammari, M. S., Syed, T., & Shamsi, A. (2025) · Antioxidants · doi:10.3390/antiox14070774 · Cited by 26
Jembrek, M. J., Leko, M. B., Pivac, N., Hof, P. R., & Šimić, G. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0144-z · Cited by 26
Metadata
- Authors
- Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A.
- Affiliations
- Northwestern University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-04-16
- Volume
- 99
- Issue
- 9
- Pages
- 6364-6369
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC122954
- OpenAlex
- W2081768153
- Cited by
- 807
- References
- 45
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 22 · 2023: 24 · 2022: 22 · 2021: 25 · 2020: 44 · 2019: 37 · 2018: 40 · 2017: 43 · 2016: 39 · 2015: 40 · 2014: 55 · 2013: 44 · 2012: 51
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag015383-02)
- National Institute on Aging (AG15383)
- National Institute of Neurological Disorders and Stroke (R01NS039080, NS 39080)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tau protein, amyloid-beta, Alzheimer's disease, neurotoxicity, neurite degeneration, hippocampal neurons, microtubules, cytoskeleton, amyloid plaques, neurofibrillary tangles, amyloid fibrils
- MeSH terms
- Animals, Brain, Central Nervous System, Cytoskeleton, Hippocampus, Humans, Immunohistochemistry, Mice, Transgenic, Microtubules, Phenotype, Immunoblotting, Blotting, Western, Amyloid beta-Peptides, tau Proteins, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.